ArticlePulmonary therapy2021

Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.

David Slade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.